![Christopher Parker](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Christopher Parker
Keine laufenden Positionen mehr
Profil
Christopher Parker served as the Managing Director for Roche Diagnostics Ltd. from 2012 to 2017 and later as the Executive Director for AnteoTech Ltd. from 2022 to 2023.
He received his undergraduate degree from Queensland University of Technology.
Ehemalige bekannte Positionen von Christopher Parker
| Unternehmen | Position | Ende |
|---|---|---|
| ANTEOTECH LIMITED | Vorstandsvorsitzender | 01.12.2019 |
Roche Diagnostics Ltd.
 Roche Diagnostics Ltd. Medical SpecialtiesHealth Technology Develops diagnostic tests and instruments | Corporate Officer/Principal | 01.07.2017 |
Ausbildung von Christopher Parker
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
5
Beziehungen ersten Grades
3
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 3 |
|---|---|
Queensland University of Technology
 Queensland University of Technology Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
AnteoTech Ltd.
 AnteoTech Ltd. Medical SpecialtiesHealth Technology Develops, manufactures and commercializes proprietary surface coatings for health care & life sciences | Health Technology |
Roche Diagnostics Ltd.
Roche Diagnostics Ltd. Medical SpecialtiesHealth Technology Develops diagnostic tests and instruments | Health Technology |
